Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy

AIDS. 2023 Jun 1;37(7):1065-1075. doi: 10.1097/QAD.0000000000003523. Epub 2023 Mar 3.

Abstract

Background: Persons with HIV (PWH) on antiretroviral therapy (ART) have persistent immune activation associated with increased risk for non-AIDS related diseases. Latent tuberculosis infection (LTBI), endemic in Africa, may contribute to this immune dysregulation. We evaluated the impact of HIV and TB co-infection on plasma pro- and anti-inflammatory cytokines among Kenyan adults.

Methods: We compared data from 221 PWH on long-term ART and 177 HIV-negative adults examining biomarkers of pro-[sCD14, interleukin (IL)-2, IL-6, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), IL-12p70, IL-17A] and anti(IL-4, IL-5, IL-13) inflammatory cytokines, by HIV/LTBI status (HIV+LTBI+, HIV+LTBI-, HIV-LTBI+, HIV-LTBI-). LTBI was diagnosed based on a positive QuantiFERON TB Gold-Plus test in the absence of active TB symptoms. Linear regression was used to evaluate the associations of HIV, LTBI, and HIV/LTBI status with biomarkers adjusting for clinical factors including HIV-specific factors.

Results: Half of the participants were women and 52% had LTBI. HIV was independently associated with higher sCD14, IL-15, IL-6, IL-4, IL-5. LTBI was independently associated with higher TNF-α, IL-12p70, IL-17A, IL-4, IL-13 in adjusted models ( P < 0.05). LTBI status was associated with higher IL-4 and IL-12p70 only among PWH, but not HIV-negative participants ( P < 0.05 for interactions). In multivariate analysis, only HIV+LTBI+ demonstrated elevated levels of TNF-α, IL-6, IL-12p70, IL-15, IL-17A, IL4, IL-5, IL-13 in comparison to the HIV-LTBI- ( P < 0.05 for all). The effect of LTBI on cytokines among PWH was independent of CD4 + T-cell count and ART duration.

Conclusions: Despite viral suppression, persons with HIV and LTBI exhibit abnormal cytokine production accompanied by high concentrations of pro- and anti-inflammatory cytokines.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents
  • Biomarkers
  • Cytokines
  • Female
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Interleukin-13
  • Interleukin-15 / therapeutic use
  • Interleukin-17
  • Interleukin-4
  • Interleukin-5 / therapeutic use
  • Interleukin-6
  • Kenya
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Lipopolysaccharide Receptors
  • Male
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Interleukin-17
  • Interleukin-15
  • Tumor Necrosis Factor-alpha
  • Interleukin-13
  • Interleukin-4
  • Interleukin-5
  • Interleukin-6
  • Lipopolysaccharide Receptors
  • Biomarkers
  • Anti-Inflammatory Agents